Market Trends of Infectious Disease Diagnostics Industry
This section covers the major market trends shaping the Infectious Disease Diagnostics Market according to our research experts:
The Human Immunodeficiency Virus (HIV) Segment is Expected to Hold a Significant Share of the Market Over the Forecast Peiod
The HIV Diagnostics Market segment is anticipated to witness significant growth during the forecast period of the study. The Minority of HIV/AIDS Fund (MHAF), United States Department of Health and Human Services Statistics, updated in June 2021, estimates that approximately 37.6 million people are living with HIV worldwide in 2020, of whom 35.9 million were adults and 1.7 million were children (under the age of 15). According to the same source, 1.5 million people will have contracted HIV globally in 2020. The Infectious Disease Diagnosis Market is expanding due to the rising prevalence of HIV and the demand for diagnostic tests and detection.
Additionally, in August 2021, the Human Rights Campaign (HRC) Foundation and "Us Helping Us" started the first in-home HIV testing program for residents in the United States. It is anticipated that the increased awareness about HIV and rising initiatives taken by various organizations worldwide will support the Infectious Disease Diagnostics Market growth during the forecast period.
It is also anticipated that new research and developments, technological advancements, and the introduction of technologically enhanced goods by key competitors will accelerate the Molecular Diagnostics Industry's expansion. For instance, in April 2021, Altona Diagnostics One introduced an in-vitro diagnostic test that identifies and quantifies the human immunodeficiency virus (HIV) specific RNA in human plasma. It was based on real-time RT-PCR technology, and the test was known as the 1.5 AltoStar HIV RT-PCR Kit.
Therefore, due to increasing HIV infections, new research and developments, and technological advancements, the Human Immunodeficiency Virus (HIV) segment is expected to witness significant growth in the Infectious Disease Diagnostic Market over the forecast period.
North America is Anticipated to Observe Significant Market Growth Over the Forecast Period
North America is expected to hold a significant share of the market. The major factors contributing to the market growth are the increasing prevalence of Infectious Diseases, high expenditure on healthcare, and an increase in awareness among the population regarding the availability of diagnostic devices. For instance, according to information released by CDC, the 2021 flu season resulted in 9 million illnesses, 4 million medical visits, and 10,000 hospitalizations in the United States. In the upcoming years, Infectious Disease Market Growth is predicted to be positively impacted by the rising burden of diseases.
In addition, in June 2021, the FDA registered Dipanjan Pan's laboratory at the University of Maryland School of Medicine (UMSOM) as an approved laboratory development site for RNA Disease Diagnostics Inc.'s Antisense COVID-19 molecular diagnostic test. The Infectious Disease Diagnostic Testing Market is therefore anticipated to have significant expansion in the region over the course of the projected period in light of the aforementioned considerations.
Additionally, the market expansion in the nation will be accelerated by strategic activities including collaborations, acquisitions, grant programmes, and others. For instance, in July 2021, Omega Specialty Nurses (OSN), House of Sophrosyne, and the Viral Hepatitis Care Network in Ontario have received grants from the 2021 CONNECT-C Grant Program from Gilead Sciences Canada, Inc. to expand the number of hepatitis screening centres across the nation. This is expected to improve the diagnosis of disease and adaptability of product and thus drives the market.
The Infectious Disease Diagnosis Market is also driven by expanding investments for improving disease model analysis. To develop linkages between the academic community, business community, and the governmental sector. For instance, in April 2021, the government of Canada formed five multidisciplinary Infectious Disease modelling networks with a total expenditure of USD 10 million. The findings will enable Canada to better respond to potential threats to public health, which will spur the industry to expand. The coordination of Infectious Disease modelling will also be considerably improved.
Therefore, due to factors such as increasing prevalence of Infectious Diseases, expanding investments for improving disease model analysis, and strategic activities including collaborations, acquisitions, grant programmes, and others, the growth of the studied market is anticipated in the North American region.
